M&T Bank Corp reduced its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 79.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,179 shares of the company's stock after selling 15,901 shares during the quarter. M&T Bank Corp's holdings in Clorox were worth $421,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of the stock. State Street Corp grew its position in shares of Clorox by 3.5% during the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company's stock worth $1,039,946,000 after buying an additional 282,794 shares during the period. Invesco Ltd. grew its position in shares of Clorox by 23.1% during the 3rd quarter. Invesco Ltd. now owns 3,995,590 shares of the company's stock worth $492,656,000 after buying an additional 750,415 shares during the period. Van ECK Associates Corp grew its position in shares of Clorox by 93.9% during the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company's stock worth $334,139,000 after buying an additional 1,312,471 shares during the period. Two Sigma Investments LP grew its position in shares of Clorox by 33.8% during the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company's stock worth $214,564,000 after buying an additional 439,797 shares during the period. Finally, Northern Trust Corp grew its position in shares of Clorox by 4.8% during the 3rd quarter. Northern Trust Corp now owns 1,539,006 shares of the company's stock worth $189,759,000 after buying an additional 70,783 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on the company. Wall Street Zen upgraded Clorox from a "sell" rating to a "hold" rating in a research report on Saturday, February 7th. JPMorgan Chase & Co. decreased their target price on Clorox from $99.00 to $95.00 and set an "underweight" rating for the company in a research report on Friday. Wells Fargo & Company decreased their target price on Clorox from $110.00 to $100.00 and set an "equal weight" rating for the company in a research report on Friday. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and issued a $91.00 price objective on shares of Clorox in a research report on Friday. Finally, TD Cowen boosted their price objective on Clorox from $98.00 to $111.00 and gave the company a "hold" rating in a research report on Tuesday, March 31st. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Reduce" and a consensus target price of $104.93.
Check Out Our Latest Report on CLX
Key Headlines Impacting Clorox
Here are the key news stories impacting Clorox this week:
- Positive Sentiment: Q3 results beat on the bottom line as cost cuts and lower spending lifted non‑GAAP EPS to $1.64, above estimates, showing operational leverage despite flat sales. Read More.
- Positive Sentiment: Management is emphasizing innovation and strategic moves to drive future growth — a narrative investors may watch if execution improves. Read More.
- Neutral Sentiment: The company provided Q3 filings, an earnings call transcript and a formal press release; these sources contain details on segment trends and cost actions for modeling. Read More. • Read More.
- Negative Sentiment: Clorox trimmed FY‑2026 guidance (EPS and sales), citing weaker demand and market‑share headwinds — management’s guidance was well below consensus, which is the main catalyst for the selloff. Read More.
- Negative Sentiment: Several large brokers cut price targets and shifted to neutral/underweight after the update (Morgan Stanley, Citi, JPMorgan, Wells Fargo), increasing short‑term selling pressure. Read More. • Read More.
- Negative Sentiment: A shareholder law firm announced an investigation into possible securities‑fraud claims related to Clorox’s statements, adding regulatory/legal risk that can weigh on sentiment. Read More.
- Negative Sentiment: Shares hit new 52‑week lows and traded at much higher volumes, signaling broad repositioning by investors and momentum that could continue until clarity on sales/margin recovery arrives. Read More.
Clorox Price Performance
Shares of CLX opened at $87.08 on Friday. The company has a debt-to-equity ratio of 71.03, a quick ratio of 0.48 and a current ratio of 0.74. The stock has a 50 day simple moving average of $108.21 and a 200 day simple moving average of $108.74. The Clorox Company has a 52-week low of $86.00 and a 52-week high of $140.24. The firm has a market capitalization of $10.53 billion, a PE ratio of 14.14, a P/E/G ratio of 0.43 and a beta of 0.59.
Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 379.46% and a net margin of 11.18%.The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period in the previous year, the firm earned $1.45 EPS. Clorox's quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Sell-side analysts predict that The Clorox Company will post 5.56 EPS for the current fiscal year.
Clorox Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, May 8th. Shareholders of record on Wednesday, April 22nd will be paid a $1.24 dividend. The ex-dividend date is Wednesday, April 22nd. This represents a $4.96 annualized dividend and a yield of 5.7%. Clorox's payout ratio is presently 81.05%.
About Clorox
(
Free Report)
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
See Also
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.